Your support is the driver of the End ME/CFS Project. Your donations spur our research and progress. Because of you, OMF has built a global network of brilliant researchers dedicated to finding a cure.
Your support is the driver of the End ME/CFS Project. Your donations spur our research and progress. Because of you, OMF has built a global network of brilliant researchers dedicated to finding a cure.
The challenges are real, but we won’t lose momentum. Not with you on our team.
We fund research projects with real-life implications for ME / CFS sufferers.
OMF is funding two exciting pilot treatment trials, Mestinon and Kynurenine. The outcome of this research will be to determine what biological factors might be relevant to their success or failure at treating the symptoms of people diagnosed with ME / CFS. Ultimately the data generated will help to better understand the pathogenesis of ME / CFS towards finding effective treatments.
In a rapid response to the recent COVID-19 pandemic, Open Medicine Foundation has launched a study to track patients with COVID-19 that have been discharged from the ICU, with the expectation that some will develop ME / CFS. The tracking of these participants will involve sample collection for testing of biological factors, continuous health tracking via wearables and symptom data collection for many separate timepoints over the course of two years.
This presents an unprecedented opportunity to study the biological factors that differentiate why some people develop ME / CFS following infection and why some people recover completely.
Open Medicine Foundation is excited to announce the initiation of a study of patients with COVID-19 to monitor the course of their disease and its …
This clinical trial will test the exercise response to Mestinon in people with ME/CFS.
Open Medicine Foundation is excited to announce its support of an initiation of a clinical trial to understand potential disturbances in the tryptophan metabolism and …
Images generously submitted by people with ME / CFS for #FlashbackFriday. Thank You!